Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/55375 |
Resumo: | Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, Brasil / Universidade de Brasilia. Faculdade de Medicina. Programa de Pós-Graduação em Saúde Coletiva. Brasília, DF, Brasil. |
id |
CRUZ_19360af9b0ec597e78b67adea1acdea4 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/55375 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Andrade, Elaine Silva NascimentoBrandão, Jurema GuerrieriSilva, Juliana Souza daCoriolano, Carmelita Ribeiro FilhaRosa, Patricia SammarcoMoraes, Milton OzórioFerreira, Cynthia de OliveiraGomes, Ciro MartinsAraújo, Wildo Navegantes de2022-10-26T19:07:29Z2022-10-26T19:07:29Z2022ANDRADE, Elaine Silva Nascimento et al. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial Agents and Chemotherapy, v,. 66, n. 5, p. 1 - 9, April 2022.1098-6596https://www.arca.fiocruz.br/handle/icict/5537510.1128/aac.02170-21engAmerican Society for MicrobiologyBrasilM. lepraeResistência à medicamentosAnálise de sequênciaDNAVigilânciaHanseníaseBrazilDrug resistanceM. lepraeSequence analysisDNASurveillanceLeprosyAntimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Planinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMinistério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, Brasil / Universidade de Brasilia. Faculdade de Medicina. Programa de Pós-Graduação em Saúde Coletiva. Brasília, DF, Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, Brasil / Universidade de Brasília. Faculdade de Medicina. Programa de Pós-Graduação em Ciências Médicas,. Brasilia, DF, Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, BrasilMinistério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, BrasilInstituto Lauro de Souza Lima, Laboratório de Biologia Molecular. Bauru, SP, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Hanseníase,. Rio de Janeiro, RJ, Brasil.Fundação Alfredo da Matta. Laboratório de Biologia Molecular. Manaus, AM, Brasil / Laboratório de Biologia Molecular. Programa de Pós-Graduação em Medicina Tropical. Manaus, AM, Brasil.Universidade de Brasília. Faculdade de Medicina. Programa de Pós-Graduação em Ciências Médicas,. Brasilia, DF, Brasil / Universidade de Brasília. Programa de Pós-Graduação em Medicina Tropical, Núcleo de Medicina Tropical,. Brasília, DF, Brasil.Universidade de Brasilia. Faculdade de Medicina. Programa de Pós-Graduação em Saúde Coletiva. Brasília, DF, Brasil / Universidade de Brasília. Programa de Pós-Graduação em Medicina Tropical, Núcleo de Medicina Tropical,. Brasília, DF, Brasil / Universidade de Brasília. Faculdade UnB Ceilândia,. Brasília, DF, Brasil / Instituto Nacional de Ciência e Tecnologia para Avaliação de Tecnologia em Saúde. Porto Alegre, RS, Brasil.Brazil ranks second among countries for new cases and first for relapse cases of leprosy worldwide. The Mycobacterium leprae Resistance Surveillance Plan was established. We aimed to present the results of a 2-year follow-up of the National Surveillance Plan in Brazil. A cross-sectional study of leprosy cases was performed to investigate antimicrobial resistance (AMR) in Brazil from October 2018 to September 2020. Molecular screening targeting genes related to dapsone (folP1), rifampin (rpoB), and ofloxacin resistance (gyrA) was performed. During the referral period, 63,520 active leprosy patients were registered in Brazil, and 1,183 fulfilled the inclusion criteria for molecular AMR investigation. In total, only 16 (1.4%) patients had genetic polymorphisms associated with AMR. Of these, 8 (50%) had cases of leprosy relapse, 7 (43.8%) had cases of suspected therapeutic failure with standard treatment, and 1 (6.2%) was a case of new leprosy presentation. M. leprae strains with AMR-associated mutations were found for all three genes screened. Isolates from two patients showed simultaneous resistance to dapsone and rifampin, indicating multidrug resistance (MDR). No significant relationship between clinical variables and the presence of AMR was identified. Our study revealed a low frequency of AMR in Brazil. Isolates were resistant mainly to dapsone, and a very low number of isolates were resistant to rifampin, the main bactericidal agent for leprosy, or presented MDR, reinforcing the importance of the standard World Health Organization multidrug therapy. The greater frequency of AMR among relapsed patients supports the need to constantly monitor this group.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/55375/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALMiltonMoraes_JulianaSSilva_etal_IOC_2022.pdfMiltonMoraes_JulianaSSilva_etal_IOC_2022.pdfapplication/pdf773372https://www.arca.fiocruz.br/bitstream/icict/55375/2/MiltonMoraes_JulianaSSilva_etal_IOC_2022.pdfec11ee7e15a4a0238e4d2e80ce424323MD52icict/553752023-09-04 11:03:02.48oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-04T14:03:02Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
title |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
spellingShingle |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan Andrade, Elaine Silva Nascimento Brasil M. leprae Resistência à medicamentos Análise de sequência DNA Vigilância Hanseníase Brazil Drug resistance M. leprae Sequence analysis DNA Surveillance Leprosy |
title_short |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
title_full |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
title_fullStr |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
title_full_unstemmed |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
title_sort |
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan |
author |
Andrade, Elaine Silva Nascimento |
author_facet |
Andrade, Elaine Silva Nascimento Brandão, Jurema Guerrieri Silva, Juliana Souza da Coriolano, Carmelita Ribeiro Filha Rosa, Patricia Sammarco Moraes, Milton Ozório Ferreira, Cynthia de Oliveira Gomes, Ciro Martins Araújo, Wildo Navegantes de |
author_role |
author |
author2 |
Brandão, Jurema Guerrieri Silva, Juliana Souza da Coriolano, Carmelita Ribeiro Filha Rosa, Patricia Sammarco Moraes, Milton Ozório Ferreira, Cynthia de Oliveira Gomes, Ciro Martins Araújo, Wildo Navegantes de |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Andrade, Elaine Silva Nascimento Brandão, Jurema Guerrieri Silva, Juliana Souza da Coriolano, Carmelita Ribeiro Filha Rosa, Patricia Sammarco Moraes, Milton Ozório Ferreira, Cynthia de Oliveira Gomes, Ciro Martins Araújo, Wildo Navegantes de |
dc.subject.other.en_US.fl_str_mv |
Brasil M. leprae Resistência à medicamentos Análise de sequência DNA Vigilância Hanseníase |
topic |
Brasil M. leprae Resistência à medicamentos Análise de sequência DNA Vigilância Hanseníase Brazil Drug resistance M. leprae Sequence analysis DNA Surveillance Leprosy |
dc.subject.en.en_US.fl_str_mv |
Brazil Drug resistance M. leprae Sequence analysis DNA Surveillance Leprosy |
description |
Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI. Coordenação Geral de Doenças em Eliminação – CGDE. Brasília, DF, Brasil / Universidade de Brasilia. Faculdade de Medicina. Programa de Pós-Graduação em Saúde Coletiva. Brasília, DF, Brasil. |
publishDate |
2022 |
dc.date.accessioned.fl_str_mv |
2022-10-26T19:07:29Z |
dc.date.available.fl_str_mv |
2022-10-26T19:07:29Z |
dc.date.issued.fl_str_mv |
2022 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ANDRADE, Elaine Silva Nascimento et al. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial Agents and Chemotherapy, v,. 66, n. 5, p. 1 - 9, April 2022. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/55375 |
dc.identifier.issn.en_US.fl_str_mv |
1098-6596 |
dc.identifier.doi.none.fl_str_mv |
10.1128/aac.02170-21 |
identifier_str_mv |
ANDRADE, Elaine Silva Nascimento et al. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial Agents and Chemotherapy, v,. 66, n. 5, p. 1 - 9, April 2022. 1098-6596 10.1128/aac.02170-21 |
url |
https://www.arca.fiocruz.br/handle/icict/55375 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/55375/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/55375/2/MiltonMoraes_JulianaSSilva_etal_IOC_2022.pdf |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 ec11ee7e15a4a0238e4d2e80ce424323 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798325035495063552 |